As Smad6 is a key protein in regulating glioma stem-like cell initiation and self-renewal, an additional concern is that MH2 protein might have inhibitory effects on cancer stem cells and reverse chemoradiotherapy resistance. The gene discussed is SMAD6; the disease is central nervous system cancer.